Search
Patexia Research
Case number 3:22-cv-05830

NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al > Documents

Date Field Doc. No.Description (Pages)
Dec 20, 2022 11 ORDER of voluntary dismissal without prejudice. Signed by Judge Zahid N. Quraishi on 12/20/2022. (jdg) Modified on 12/20/2022 (jdg, ). (Entered: 12/20/2022) (2)
Dec 19, 2022 10 NOTICE of Voluntary Dismissal by NEUROCRINE BIOSCIENCES, INC. (ARTILES, GUILLERMO) (Entered: 12/19/2022) (2)
Oct 31, 2022 6 WAIVER OF SERVICE Returned Executed by NEUROCRINE BIOSCIENCES, INC.. (SKLAR, MATTHEW) (Entered: 10/31/2022) (1)
Oct 31, 2022 7 WAIVER OF SERVICE Returned Executed by NEUROCRINE BIOSCIENCES, INC.. (SKLAR, MATTHEW) (Entered: 10/31/2022) (1)
Oct 31, 2022 8 WAIVER OF SERVICE Returned Executed by NEUROCRINE BIOSCIENCES, INC.. (SKLAR, MATTHEW) (Entered: 10/31/2022) (1)
Oct 31, 2022 9 WAIVER OF SERVICE Returned Executed by NEUROCRINE BIOSCIENCES, INC.. (SKLAR, MATTHEW) (Entered: 10/31/2022) (1)
Oct 3, 2022 3 AO120 Patent/Trademark Form filed. (kht) (Entered: 10/03/2022) (1)
Oct 3, 2022 4 SUMMONS ISSUED as to ZYDUS HEALTHCARE (USA) LLC, ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (kht) (Entered: 10/03/2022) (2)
Oct 3, 2022 5 NOTICE of Appearance by MATTHEW ADAM SKLAR on behalf of NEUROCRINE BIOSCIENCES, INC. (SKLAR, MATTHEW) (Entered: 10/03/2022) (2)
Sep 30, 2022 1 Complaint* (1)
Sep 30, 2022 2 Corporate Disclosure Statement by NEUROCRINE BIOSCIENCES, INC.. (ARTILES, GUILLERMO) (Entered: 09/30/2022) (2)
Menu